Showing 641 - 660 results of 1,151 for search '"central nervous system"', query time: 0.07s Refine Results
  1. 641

    Severe Cases of Tick-Borne Encephalitis in Northeastern Poland by Justyna Adamczuk, Magdalena Chlabicz, Natalia Koda, Maciej Kondrusik, Joanna Zajkowska, Piotr Czupryna, Anna Moniuszko-Malinowska

    Published 2024-12-01
    “…Tick-borne encephalitis (TBE) is the most prevalent viral infection of the central nervous system (CNS) in Poland. The disease is characterized by the presence of two stages. …”
    Get full text
    Article
  2. 642

    A Concurrent Cognitive Task Does Not Perturb Quiet Standing in Fibromyalgia and Chronic Fatigue Syndrome by Omid Rasouli, Egil A. Fors, Ottar Vasseljen, Ann-Katrin Stensdotter

    Published 2018-01-01
    “…Fatigue as well as pain may require greater effort to perform cognitive tasks, thereby increasing the load on processing in the central nervous system and interfering with motor control. …”
    Get full text
    Article
  3. 643

    Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review by Amber N. Edinoff, Keerthiga Raveendran, Marc A. Colon, Bennett H. Thomas, Katie A. Trettin, Grace W. Hunt, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye

    Published 2022-11-01
    “…A leading hypothesis of the pathophysiology of MDD is the monoamine deficiency hypothesis which suggests that depression is caused by depletion of serotonin, norepinephrine, or dopamine in the central nervous system. Serotonin is the most widely studied neurotransmitter in the pathophysiology of depression, with studies showing that reduced central serotonin synthesis leads to depressive symptoms in individuals at risk for depression. …”
    Get full text
    Article
  4. 644

    Prediction of Survival Outcomes in Patients with Glioma Using Magnetic Resonance Imaging (MRI): A Systematic Review and Meta-Analysis by Mingfang Hu, Jinge Li, Zhangyu Li, Jian Shen

    Published 2025-01-01
    “…Background: Glioma is the most common malignancy in the central nervous system. Even with optimal therapies, glioblastoma (the most aggressive form of glioma) is incurable, with only 26.5% of patients having a 2-year survival rate. …”
    Get full text
    Article
  5. 645

    Effect of Functional Electrical Stimulation on Improving Upper Extremity Motor Function in Stroke Patients Revealed by fMRI:a Controlled Study by Fangfang ZHENG, Huihua LIU, Tiebin YAN, Xiaokun JIN, Xiaohui DUAN, Jun SHEN

    Published 2015-10-01
    “…Objective:To investigate the effect of functional electrical stimulation (FES) on brain function by using functional magnetic resonance imaging (fMRI), and further explore the mechanism of FES on central nervous system rehabilitation in patients with sub-cortical stroke.Methods:Ten subjects were recruited in the study, including five stroke patients (stroke group) and five age-and-gender-matched healthy persons (control group). …”
    Get full text
    Article
  6. 646

    Visual Features in Alzheimer’s Disease: From Basic Mechanisms to Clinical Overview by María Alejandra Cerquera-Jaramillo, Mauricio O. Nava-Mesa, Rodrigo E. González-Reyes, Carlos Tellez-Conti, Alejandra de-la-Torre

    Published 2018-01-01
    “…The visual system and central nervous system share many functional components. Thus, it is plausible that damage induced by Aβ, tau, and neuroinflammation may be observed in visual components such as the retina, even at an early disease stage. …”
    Get full text
    Article
  7. 647

    Laboratory biomarkers for multiple sclerosis and their role in clinical practice by I. Navickaitë, G. Žemgulytė, R. Balnytė

    Published 2023-11-01
    “… Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) most commonly diagnosed in young adults. …”
    Get full text
    Article
  8. 648

    Role of aquaporins in brain water transport and edema by Yuyuan Li, Yining Wang, Xingda Huang, Hao Zhang, Youfei Guan, Xiaoyan Zhang

    Published 2025-01-01
    “…Water serves as the primary substance in all living cells and is an essential molecule involved in numerous biological processes critical for maintaining homeostasis in the central nervous system (CNS). Disruptions in water balance can occur in conditions such as cerebral edema, where fluid accumulation results in increased intracranial pressure (ICP). …”
    Get full text
    Article
  9. 649

    Narrative Literature Review of Potential Atrial Fibrillation Mechanism of Action Induced by Discontinuation of Benzodiazepines by Agnė Okulevičiūtė, Gabija Laubner Sakalauskienė

    Published 2023-11-01
    “…They interact with GABA-A receptors, causing hyperpolarization and inhibitory effects in the central nervous system. BZDs are used to treat various clinical disorders, but long-term use can lead to adverse effects and withdrawal symptoms. …”
    Get full text
    Article
  10. 650

    Thioflavin-T: application as a neuronal body and nucleolar stain and the blue light photo enhancement effect by Jin-Hong Min, Heela Sarlus, Sho Oasa, Robert A. Harris

    Published 2024-10-01
    “…We believe that this is of value for any lab that studies central nervous system (CNS) tissues. Furthermore, we show that THT could potentially be used as a an alternative to the use of fluorescent reporters or other more costly RNA binding compounds in the study of nucleolar dynamics owing to its ability to clearly stain nucleoli in live cells. …”
    Get full text
    Article
  11. 651

    Dialectics and Implications of Natural Neurotropic Autoantibodies in Neurological Disease and Rehabilitation by A. B. Poletaev, A. A. Abrosimova, M. A. Sokolov, A. B. Gekht, V. V. Alferova, E. I. Gusev, T. Ya. Nikolaeva, C. Selmi

    Published 2004-01-01
    “…In particular, limited experimental evidence has been provided concerning the qualitative and quantitative serological response after acute injuries of the central nervous system or during chronic mental diseases. …”
    Get full text
    Article
  12. 652

    Electroencephalographic Features of Presumed Hepatic Encephalopathy in a Pediatric Dog with a Portosystemic Shunt—A Case Report by Raluca Adriana Ștefănescu, Vasile Boghian, Gheorghe Solcan, Mario Darius Codreanu, Mihai Musteata

    Published 2025-01-01
    “…Hepatic encephalopathy (HE) in dogs is a metabolic disorder of the central nervous system that occurs secondarily to liver dysfunctions, whether due to acquired or congenital causes. …”
    Get full text
    Article
  13. 653

    A Preliminary Investigation into the Neural Correlates of Knee Loading during a Change of Direction Task in Individuals after Anterior Cruciate Ligament Reconstruction by Adam Culiver, Dustin Grooms, Nathan Edwards, Laura Schmitt, James Oñate

    Published 2023-02-01
    “…# Background Central nervous system (CNS) function after ACLR, quantified by the blood oxygen level dependent (BOLD) response, is altered in regions of sensory function during knee movement after ACLR. …”
    Get full text
    Article
  14. 654

    Sodium Butyrate Protects N2a Cells against Aβ Toxicity In Vitro by Jingxuan Sun, Boyu Yuan, Yancheng Wu, Yuhong Gong, Wenjin Guo, Shoupeng Fu, Yongxin Luan, Wei Wang

    Published 2020-01-01
    “…Sodium butyrate (NaB) is a short-chain fatty acid salt that exerts neuroprotective effects such as anti-inflammatory, antioxidant, antiapoptotic, and cognitive improvement in central nervous system diseases. The aim of this study is to research the protective effects of NaB on neurons against Aβ toxicity and to uncover the underlying mechanisms. …”
    Get full text
    Article
  15. 655

    The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects by Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy

    Published 2025-06-01
    “…Central nervous system disorders are likely to have a substantial effect on the worldwide healthcare demands of humanity in this era. …”
    Get full text
    Article
  16. 656

    Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma by Zhengyuan Huo, Shaorui Gu, Zheng Bian, Wenli Wang, Zhifeng Jiang

    Published 2024-01-01
    “…Gliomas are primary malignant tumors of the central nervous system. The TEA domain transcription factor (TEAD) family proteins are the ultimate effector molecules of the Hippo pathway. …”
    Get full text
    Article
  17. 657

    Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression by Georgia Tsaouli, Elisabetta Ferretti, Diana Bellavia, Alessandra Vacca, Maria Pia Felli

    Published 2019-01-01
    “…In children, there is 25% chance of disease relapse, typically in the central nervous system. While in adults, there is a higher chance of relapse. …”
    Get full text
    Article
  18. 658

    IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels by José Fernando Maya-Vetencourt, Laura Baroncelli, Alessandro Viegi, Ettore Tiraboschi, Eero Castren, Antonino Cattaneo, Lamberto Maffei

    Published 2012-01-01
    “…The central nervous system architecture is markedly modified by sensory experience during early life, but a decline of plasticity occurs with age. …”
    Get full text
    Article
  19. 659

    Hyaluronan Synthesis, Catabolism, and Signaling in Neurodegenerative Diseases by Larry S. Sherman, Steven Matsumoto, Weiping Su, Taasin Srivastava, Stephen A. Back

    Published 2015-01-01
    “…The glycosaminoglycan hyaluronan (HA), a component of the extracellular matrix, has been implicated in regulating neural differentiation, survival, proliferation, migration, and cell signaling in the mammalian central nervous system (CNS). HA is found throughout the CNS as a constituent of proteoglycans, especially within perineuronal nets that have been implicated in regulating neuronal activity. …”
    Get full text
    Article
  20. 660

    Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis by Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales

    Published 2022-10-01
    “…<p><strong>Background:</strong> multiple sclerosis modifying drugs are intended to reduce the frequency of relapses, delay the progression of disability, as well as the appearance of new lesions in the Central Nervous System.<br /><strong>Objective:</strong> to determine the early indicators of response to treatment with IFNb-1a.…”
    Get full text
    Article